Loading
Latest filing published 30 Mar 2024 for Aurobindo Pharma Limited, €140.5M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
RPR SONS ADVISORS PVT.LTD., P.SUNEELA RANI (Jointly holding) discloses dealings in Aurobindo Pharma Limited to SEBI (PIT + SAST). We count 63 filings; the first trade dates from 1 March 2021 and the latest from 30 March 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 30 March 2024 came the latest disclosure, a transaction for €140.5M in Aurobindo Pharma Limited. Typically, a trade is published a median of 2 days after it takes place. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 63 declarations